5,276 reports of this reaction
2.2% of all BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE reports
#8 most reported adverse reaction
FATIGUE is the #8 most commonly reported adverse reaction for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, manufactured by AstraZeneca Pharmaceuticals LP. There are 5,276 FDA adverse event reports linking BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE to FATIGUE. This represents approximately 2.2% of all 236,943 adverse event reports for this drug.
Patients taking BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 5,276 FDA reports for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.2% of all adverse event reports for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, making it a notable side effect.
If you experience fatigue while taking BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.